Future Oncology: Difference between revisions
Appearance
Content deleted Content added
linking |
Laura Dormer (talk | contribs) m Updated impact factor following new JCR release; corrected publication frequency |
||
Line 9: | Line 9: | ||
| country = |
| country = |
||
| history = 2005–present |
| history = 2005–present |
||
| frequency = |
| frequency = 30 issues/year |
||
| openaccess = |
| openaccess = |
||
| license = |
| license = |
||
| impact = 2. |
| impact = 2.131 |
||
| impact-year = |
| impact-year = 2016 |
||
| ISSN = 1479-6694 |
| ISSN = 1479-6694 |
||
| eISSN = 1744-8301 |
| eISSN = 1744-8301 |
||
Line 26: | Line 26: | ||
| link2-name = <!-- up to |link5-name= --> |
| link2-name = <!-- up to |link5-name= --> |
||
}} |
}} |
||
'''''Future Oncology''''' is a |
'''''Future Oncology''''' is a [[peer-reviewed]] [[medical journal]] established in 2005 and published by Future Medicine. It covers all aspects of [[oncology]]. The [[editors-in-chief]] are Ron Allison (21st Century Oncology) and Adam Dicker ([[Thomas Jefferson University]]). |
||
== Abstracting and indexing== |
== Abstracting and indexing== |
||
The journal is abstracted and indexed in [[CINAHL Plus]], [[Chemical Abstracts]], [[Current Contents]]/Clinical Medicine, [[EMBASE]]/[[Excerpta Medica]], [[Index Medicus]]/[[MEDLINE]]/[[PubMed]], [[Science Citation Index Expanded]], and [[Scopus]]. According to the ''[[Journal Citation Reports]]'', the journal has a |
The journal is abstracted and indexed in [[CINAHL Plus]], [[Chemical Abstracts]], [[Current Contents]]/Clinical Medicine, [[EMBASE]]/[[Excerpta Medica]], [[Index Medicus]]/[[MEDLINE]]/[[PubMed]], [[Science Citation Index Expanded]], and [[Scopus]]. According to the ''[[Journal Citation Reports]]'', the journal has a 2016 [[impact factor]] of 2.131, ranking it 152nd out of 217 journals in the category "Oncology".<ref name=WoS>{{cite book |year=2017 |chapter=Journals Ranked by Impact: Oncology |title=2016 Journal Citation Reports |publisher=[[Thomson Reuters]] |edition=Science |series=[[Web of Science]]}}</ref> |
||
== References == |
== References == |
Revision as of 11:24, 29 June 2017
Discipline | Oncology |
---|---|
Language | English |
Edited by | Ron Allison, Adam Dicker |
Publication details | |
History | 2005–present |
Publisher | |
Frequency | 30 issues/year |
2.131 (2016) | |
Standard abbreviations | |
ISO 4 | Future Oncol. |
Indexing | |
CODEN | FOUNBN |
ISSN | 1479-6694 (print) 1744-8301 (web) |
OCLC no. | 66402835 |
Links | |
Future Oncology is a peer-reviewed medical journal established in 2005 and published by Future Medicine. It covers all aspects of oncology. The editors-in-chief are Ron Allison (21st Century Oncology) and Adam Dicker (Thomas Jefferson University).
Abstracting and indexing
The journal is abstracted and indexed in CINAHL Plus, Chemical Abstracts, Current Contents/Clinical Medicine, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.131, ranking it 152nd out of 217 journals in the category "Oncology".[1]
References
- ^ "Journals Ranked by Impact: Oncology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.